首页 | 本学科首页   官方微博 | 高级检索  
     

亚低温治疗缺氧缺血性脑病的参数与疗效相关性的系统综述
引用本文:邹仙,苗静琨,李春,陈启雄. 亚低温治疗缺氧缺血性脑病的参数与疗效相关性的系统综述[J]. 儿科药学杂志, 2021, 27(12): 1-6. DOI: 10.13407/j.cnki.jpp.1672-108X.2021.12.001
作者姓名:邹仙  苗静琨  李春  陈启雄
作者单位:重庆医科大学附属儿童医院,儿童发育疾病研究教育部重点实验室,国家儿童健康与疾病临床医学研究中心,儿童发育重大疾病国家国际科技合作基地,儿科学重庆市重点实验室,重庆 400014
摘    要:目的:总结亚低温治疗新生儿缺氧缺血性脑病时的参数调节,为临床医师提供参考.方法:检索PubMed、the Cochrane Library、Web of Science等数据库,收集亚低温治疗缺氧缺血性脑病时参数比较相关文献,应用Cochrane风险评估工具评估随机对照试验(RCT)的方法学质量,使用纽卡斯尔-渥太华量...

关 键 词:缺氧缺血性脑病  亚低温  参数  系统综述

Systematic Review of Correlation between Parameters and Efficacy of Mild Hypothermia in the Treatment of Hypoxic-Ischemic Encephalopathy
Zou Xian,Miao Jingkun,Li Chun,Chen Qixiong. Systematic Review of Correlation between Parameters and Efficacy of Mild Hypothermia in the Treatment of Hypoxic-Ischemic Encephalopathy[J]. Journal of Pediatric Pharmacy, 2021, 27(12): 1-6. DOI: 10.13407/j.cnki.jpp.1672-108X.2021.12.001
Authors:Zou Xian  Miao Jingkun  Li Chun  Chen Qixiong
Abstract:Objective: To summarize the parameter adjustment of mild hypothermia in the treatment of neonatal hypoxic-ischemic encephalopathy, so as to provide reference for clinicians. Methods: PubMed, the Cochrane Library and Web of Science database were retrieved to collect the related literature of mild hypothermia in the treatment of hypoxic-ischemic encephalopathy. Methodological quality of randomized controlled trials (RCT) was assessed by using the Cochrane risk assessment tool, and the quality of observational studies was evaluated by using the Newcastle-Ottawa scale (NOS). Results: Fourteen articles were enrolled in the study, including 6 RCT and 8 observational studies. Mild hypothermia temperature and course of treatment were classified as level I evidence factor, with high credibility that longer and lower temperature did not improve the prognosis, but increased the incidence of adverse events. The onset of mild hypothermia was classified as level II evidence factor, indicating that starting mild hypothermia treatment as early as possible could better improve the prognosis, and it was still partially effective even after 6 h, especially for moderate hypoxic-ischemic encephalopathy. The treatment of mild hypothermia (systemic vs. local mild hypothermia) was classified as level III evidence factor, which might be helpful in predicting the neuroprotective effects of two different mild hypothermia methods. Conclusion: This study preliminarily explores the influence of mild hypothermia parameters on the prognosis of hypoxic-ischemic encephalopathy, and provides reference for the prognosis research. The current study supports the strategy of mild hypothermia from 33.5 to 34.0 °C for 72 h. Regardless of the type of mild hypothermia, it is recommended to start the treatment as soon as possible, even if more than 6 h after birth, therapeutic hypothermia is still partly effective.
Keywords:hypoxic-ischaemic encephalopathy   mild hypothermia   parameters   systematic review
本文献已被 万方数据 等数据库收录!
点击此处可从《儿科药学杂志》浏览原始摘要信息
点击此处可从《儿科药学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号